𝗚𝗼𝗼𝗴𝗹𝗲 𝗔𝗹𝗽𝗵𝗮𝗚𝗲𝗻𝗼𝗺𝗲 𝘃𝘀 𝗡𝗩𝗜𝗗𝗜𝗔 𝗘𝘃𝗼𝟮

𝗚𝗼𝗼𝗴𝗹𝗲 𝗔𝗹𝗽𝗵𝗮𝗚𝗲𝗻𝗼𝗺𝗲 𝘃𝘀 𝗡𝗩𝗜𝗗𝗜𝗔 𝗘𝘃𝗼𝟮

Google DeepMind released AlphaGenome. NVIDIA released Evo2 earlier this year. Both tools change how we approach precision medicine.

Here is how they differ:

AlphaGenome This tool focuses on human DNA. It looks at non-coding regions. Scientists used to call these regions junk DNA. Now we know they control how genes turn on or off.

• It analyzes up to one million DNA base pairs.
• It predicts how gene mutations affect molecular traits.
• It helps doctors understand disease causes.
• Think of it as a precise human gene predictor and medical consultant.

Evo2 This model works like a large language model for biology. It handles DNA, RNA, and proteins across many species.

• It predicts how mutations affect proteins and RNA.
• It works on bacteria and complex organisms.
• It has generative capabilities to design new biological systems.
• It can design tools like CRISPR-Cas systems.
• Think of it as a biological engineer that writes new genetic code.

The Difference

AlphaGenome helps with human diagnosis and treatment planning. It reads the existing instructions in our bodies.

Evo2 helps with biological creation. It understands the language of life across all species to build new solutions.

These tools show the potential of AI in medicine. We will see better diagnostics and new treatments soon.

Source: https://dev.to/jh5_pulse/google-alphagenome-yu-nvidia-evo2-ru-he-gai-xie-jing-zhun-yi-liao--2d18

Optional learning community: https://t.me/GyaanSetuAi